Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Avastin study in ovarian cancer meets primary endpoint

February 25, 2010 Research and Development Cancer, avastin, ovarian

Preliminary results from a trial of Roche’s Avastin in advanced ovarian cancer suggest that the drug lengthens progression-free survival when …
News

Sanofi’s breast cancer candidate tipped for future success

February 25, 2010 Research and Development, Sales and Marketing BSI-201, Sanofi-Aventis, breast cancer

A Sanofi-Aventis drug currently in phase III has been predicted as a future blockbuster in breast cancer treatment. Sanofi’s BSI-201 …
News

Avastin fails in phase III study

February 24, 2010 Research and Development Roche, avastin, gastric cancer, stomach cancer

Roche’s Avastin does not help patients with a severe form of stomach cancer to live longer, according to the results …
News

Methylene blue poised to move into the clinic

February 24, 2010 Manufacturing and Production, Research and Development Novasep, ProveBlue, Provepharm, malaria

A new purer form of the reagent methylene blue could take the compound out of the testing laboratory and into …
News
IcahnWebV

Predatory Icahn moves in on weakened Genzyme

February 23, 2010 Research and Development, Sales and Marketing Gaucher, Genzyme, Icahn

Corporate raider Carl Icahn has made a bid to gain control of beleaguered Genzyme as it struggles to overcome major …
News
Avandia

Reports raise fresh Avandia safety questions

February 23, 2010 Research and Development, Sales and Marketing Avandia, GlaxoSmithKline, diabetes

GlaxoSmithKline’s troubled diabetes drug Avandia has been hit by fresh reports from the US that it increases the risk of …
News

Pfizer, Lilly and Merck partner for cancer research

February 23, 2010 Research and Development Asia, Cancer, developing world, em, emerging markets

Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …
News

Digital Pharma: Searching for clinical trials

February 23, 2010 Research and Development CRO, TrialReach, digi, digital pharma, digital pharma research, digital research, patient recruitment

A new clinical trials search and referral engine has launched to help patients who are considering taking part in a …
Feature

Chiltern Announces Partnership with Charles River

February 23, 2010 Research and Development

News
Press release

Lilly UK appoints Ramona Sequeira managing director

February 23, 2010 Research and Development, Sales and Marketing appointment, lilly, research and development, sales and marketing

Lilly UK has appointed Ramona Sequeira managing director, UK and Republic of Ireland.She replaces Andrew Hotchkiss who becomes vice president …
Appointment
Brain picture

Novartis gains edge in MS treatment race

February 22, 2010 Research and Development, Sales and Marketing Cladribine, Gilenia, MS, Novartis

Novartis’ new oral multiple sclerosis treatment Gilenia will be given a priority review by the FDA.This could lead to a …
News

ReNeuron to begin landmark stem cell trial for stroke

February 19, 2010 Research and Development ReNeuron, stem cell

ReNeuron has been given the go-ahead to begin clinical trials of the first ever stem cell therapy for patients disabled …
News

Clinipace appoints Bud Owen and Daryl Porter

February 19, 2010 Research and Development Clinipace, appointment, research and development

CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has …
Appointment

Dr Jay Feingold joins Daiichi Sankyo

February 19, 2010 Research and Development Daiichi Sankyo, appointment, research and development

Daiichi Sankyo’s US arm has appointed Dr Jay Feingold vice president of medical affairs. In this role his will manage …
Appointment

Merck’s HIV treatment fails in phase III

February 18, 2010 Research and Development HIV, Merck

Merck’s HIV treatment vicriviroc has disappointed in phase III trials, and may be dropped by the company. The results failed …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026